Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085430 · ClinicalTrials.gov registry record · NA
Kubota Glass Parameter Refinement Study
A NA study, sponsored by Kubota Vision.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT06085430: Completed NA study, sponsored by Kubota Vision.
NCT06085430 is a NA study that has completed, run by Kubota Vision. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06085430, a NA study, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Length of the eye will be measured in subjects exposed to various stimulus characteristics using an electronic spectacle which presents illuminated targets to the eye. The results will be analyzed to determine which stimulus characteristics may be most beneficial for use in the device.
Primary Outcome
Change in axial length as measured by optical biometry after the use of Kubota Glass
Interventions
- DEVICE Kubota Glass
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT06085430 record still lists
NCT06085430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Kubota Glass is the first listed.
NCT06085430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06085430 about?
NCT06085430 is a clinical study titled "Kubota Glass Parameter Refinement Study". Length of the eye will be measured in subjects exposed to various stimulus characteristics using an electronic spectacle which presents illuminated targets to the eye. The results will be analyzed to determine which stimulus characteristics may be most beneficial for use in the device.
What is the current status of trial NCT06085430?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-11-01. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT06085430?
The interventions under investigation include: Kubota Glass (DEVICE).
Who is sponsoring clinical trial NCT06085430?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06085430's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI